Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05268_nanopub.RAwTB_dHhkaZ4gl-L3-5pH15NE3aUVImy3Nefv2yBjWDE#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05268 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05268 label "iCo-007 [drugbank:DB05268]" assertion.
- drugbank:DB05268 seeAlso DB05268 assertion.
- drugbank:DB05268 description "iCo-007 (formerly known as ISIS 13650) is a second generation antisense compound being developed by iCo for the treatment of various eye diseases caused by the formation of new blood vessels (angiogenesis) such as age-related macular degeneration (AMD) and diabetic retinopathy(DR)." assertion.
- drugbank:DB05268 identifier "drugbank:DB05268" assertion.
- drugbank:DB05268 title "iCo-007" assertion.
- drugbank:DB05268 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05268 drugbank_vocabulary:drugbank-id "DB05268" assertion.
- drugbank:DB05268 bio2rdf_vocabulary:x-identifiers.org DB05268 assertion.
- drugbank:DB05268 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05268" assertion.
- drugbank:DB05268 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05268 bio2rdf_vocabulary:identifier "DB05268" assertion.